Teplizumab (CD3) - Research Grade Biosimilar
Product Specifications
Background
This is anti-CD3 monoclonal antibody used to prevent or delay the development of clinical type 1 diabetes (T1D) in high-risk groups. High-risk groups refer to the presence of 2 or more T1D-related autoantibodies in the body.
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Other Product Names
MGA-031/MGA031; PRV-031
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
